Dilemmas in the reliable estimation of the in-vitro cell viability in magnetic nanoparticle engineering: Which tests and what protocols?

Nanoscale Research Letters

Volumn 7, Issue , 2012, Pages

  Hoskins, Clare ^a   Wang, Lijun ^a   Cheng, Woei Ping ^b   Cuschieri, Alfred ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Cell viability assay; Cellular interaction; Cytotoxicity; Magnetic nanoparticle; Zeta potential

Indexed keywords

BIOCOMPATIBILITY; CELLS; CYTOLOGY; CYTOTOXICITY; IRON OXIDES; MAMMALS; NANOMAGNETICS; NANOPARTICLES; POLYETHYLENE GLYCOLS; SURFACE CHARGE; ZETA POTENTIAL;

CELL MEMBRANE DAMAGES; CELL VIABILITY ASSAYS; CELLULAR INTERACTION; LIPID PEROXIDATION; MAGNETIC NANO-PARTICLES; POLY(ETHYLENIMINE); POSITIVE SURFACE CHARGE; REACTIVE OXYGEN SPECIES;

CELL ENGINEERING;

MAMMALIA;

EID: 84862971823     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-7-77     Document Type: Article

References (38)

1. McCarthy JR, Weissleder R: Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliver Rev 2008, 60:1241-1251.
2. Shubayev VI, Pisanic TR, Jin S: Magnetic nanoparticles for theragnostics. Adv Drug Deliver Rev 2009, 61:467-477.
3. Bulte JWM, Douglas T, Witwer B, Zhang S-C, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA: Magnetodendrimers allow endosomal magnetic labelling and in vivo tracking of stem cells. Nat Biotechnol 2001, 19:1141-1147.
4. Syková E, Jendelová P: Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ 2007, 14:1336-1342.
5. Veiseh O, Gunn JW, Zhang M: Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliver Rev 2010, 62:284-304.
6. Wang YXJ, Hussain SM, Krestin GP: Superparamagnetic iron oxide contrast agents: physiochemical characteristics and applications in MR imaging. Eur Radiol 2001, 11:2319-2684.
7. Bonnemain B: Superparamagnetic agents in magnetic resonance imaging: Physiochemical characteristics and clinical applications - a Review. J Drug Target 1998, 6:167-174.
8. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN: Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physiochemical characterizations and biological applications. Chem Rev 2008, 108:2064-2110.
9. Sun C, Lee JSH, Zhang MQ: Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliver Rev 2008, 60:1252-1265.
10. Häfeli OU, Riffle JS, Harris-Shekhawat l, Carmichael-Baranauskas A, Mark F, Dalley JP, Bardenstein D: Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharm 2009, 6:1417-1428.
11. Fisichella M, Dabboue H, Bhattacharyya S, Saboungi M-L, Salvetat J-P, Hevor T, Guerin M: Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol in Vitro 2009, 23:697-703.
12. Belyanskaya L, Manser P, Spohn P, Bruinink A, Wick P: The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction. Carbon 2007, 45:2643-2648.
13. Casey A, Herzog E, Davoren M, Lyng FM, Byrne HJ, Chambers G: Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity. Carbon 2007, 45:1425-1432.
14. Wörle-Knirsch JM, Pulskamp K, Krug HF: Oops they did it again! Carbon nanotubes hoax scientists in viability assays. NanoLett 2006, 6:1261-1268.
15. Shvedova AA, Kisin ER, Schute P, Kagan VE, Fadeel B, Castranova V: Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: two faces of Janus. Pharmacol Therapeut 2009, 121:192-204.
16. Cheng C, Müller KH, Koziol KKK, Skepper JN, Midgley PA, Welland ME, Porter AE: Toxicity and imaging of multi-walled carbon nanotubes in human macrophage cells. Biomaterials 2009, 30:4152-4160.
17. Monteiro-Piviere NA, Inman AO: Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 2006, 44:1070-1078.
18. Davoren M, Herzog E, Casey A, Cottineau B, Chambers G, Byrne HJ, Lying FM: In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol in Vitro 2007, 21:438-448.
19. Gupta AK, Gupta M: Synthesis and surface engineering or iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
20. Figuerola A, Di Corato R, Manna L, Pellegrino T: From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharmacol Res 2010, 62:126-143.
21. Steitz B, Hofmann H, Kamau SW, Hassa PO, Hottiger MO, von Rechenberg B, Hofmann-Amtenbrink M, Petri-Fink A: Characterization of PEI-coated superparamagnetic iron oxide nanoparticles for transfection: size distribution, colloidal properties and DNA interaction. J Magn Magn Mater 2007, 311:300-305.
22. Petri-Fink A, Steitz B, Finka A, Salaklang J, Hofmann H: Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity and cellular uptake studies. Eur J Pharm Biopharm 2008, 68:129-137.
23. Leng Y, Sato K, Li J-G, Ishigaki T, Iijima M, Kamiya H, Yoshida T: Iron nanoparticles dispersible in both ethanol and water for direct silica coating. Powder Technol 2009, 196:80-84.
24. Peng J, Zou F, Liu L, Tang L, Yu L, Chen W, Liu H, Tang J-B., Wu L-x: Preparation and characterization of PEG-PEI/Fe3o4 nano-magnetic fluid by co-precipitation method. Trans Nonferrous Met Soc China 2008, 18:393-398.
25. Vila A, Gill H, McCallion O, Alonso MJ: Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release 2004, 98:231-244.
26. Józejczak A, Skumiel A: Ultrasonic investigation of magnetic nanoparticles suspension with PEG biocompatible coating. J Magn Magn Mater 2011, 11:1509-1516.
27. Douziech-Eyrolles I, Marchais H, Hervé K, Munnier E, Soucé M, Linassier C, Dubois P, Chourpa: Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles. Int J Nanomedicine 2007, 2:541-550.
28. Komuro I, Keicho N, Iwamoto A, Akagawa KS: Human alveolar macrophages and granulocyte-macrophage colony-stimulating factor- induced monocyte-derived macrophages are resistant to H2O2 via their high basal and inducible levels of catalase activity. J Biol Chem 2001, 276:24360-24364.
29. Mishra S, Webster P, Davis ME: PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur J Cell Biol 2004, 83:97-111.
30. Auffan M, Rose J, Wiesner MR, Bottero J-Y: Chemical stability of metallic nanoparticles: a paramtere controlling their potential cellular toxicity in vitro. Environmental Pollution 2009, 157:1127-1133.
31. Zhang S, Kucharski C, Doschak MR, Sebald W, Iludag H: Polyethylenimine- PEG coated albumin nanoparticles for BMP-2 delivery. Biomaterials 2010, 31:952-963.
32. Fadeel B, Garcia-Bennett AE: Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliver Rev 2010, 62:362-374.
33. Cole AJ, David AE, Wang J, Galbán CJ, Hill HL, Yang VC: Polyethylene glycol modified, cross-lined starch-coated iron oxide nanoparticles for enhanced magnetic tumour targeting. Biomaterials 2011, 32:2183-2193.
34. Aravindan L, Bicknell KA, Brooks G, Khutoryanskiy VV, Williams AC: Effect of acyl chain length on transfection efficiency and toxicity of polyethlyenimine. Int J Pharm 2009, 378:201-210.
35. Moffatt S, Cristiano RJ: Uptake characteristics of NGR-coupled stealth PEI/pDNA nanoparticles loaded with PLGA-PEG-PLGA tri-block copolymer for targeted delivery to human monocyte-derived dentritic cells. Int J Pharm 2006, 321:143-154.
36. Photos PJ, Bacakova L, Discher B, Bates FS, Discher DE: Polymer vesicles in vivo: correlations with PEG molecular weight. J Control Release 2003, 90:323-334.
37. Li S-D, Huang L: Stealth nanoparticles: high density but sheddable PEG is a key for tumour targeting. J Control Release 2010, 145:178-181.
38. Feng B, Hong RY, Wang LS, Guo L, Li HZ, Ding J, Zheng Y, Wei DG: Synthesis of Fe3o4/APTES/PEG diacid functionalised magnetic nanoparticles for MR imaging. Colloid Surface A 2008, 328:52-59.